Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
UMC Utrecht
University of Chicago
University of California, Irvine
Hospices Civils de Lyon
University Health Network, Toronto
Kaiser Permanente
Duke University
Washington University School of Medicine
Baylor College of Medicine
University of Colorado, Denver
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
University of Nebraska
Kidney Cancer Research Bureau
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Brigham and Women's Hospital
The Netherlands Cancer Institute
University of Illinois at Chicago
Rutgers, The State University of New Jersey
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Maastricht Radiation Oncology
British Columbia Cancer Agency
Washington University School of Medicine
Kansas State University
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Milton S. Hershey Medical Center
Centre for Research and Technology Hellas
Sichuan Enray Pharmaceutical Sciences Company
University of California, Irvine
University of Alabama at Birmingham
The Second Affiliated Hospital of Hainan Medical University
Columbia University
International Agency for Research on Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Arbeitsgemeinschaft medikamentoese Tumortherapie
Inova Health Care Services
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
Algemeen Ziekenhuis Maria Middelares
Cyprus University of Technology
University Health Network, Toronto
Medical University of South Carolina
Universidade Federal de Pernambuco
UNICANCER
The New York Proton Center
University of California, Davis